home / stock / eqrx / eqrx quote
Last: | $2.34 |
---|---|
Change Percent: | -2.14% |
Open: | $2.39 |
Close: | $2.34 |
High: | $2.42 |
Low: | $2.32 |
Volume: | 16,554,640 |
Last Trade Date Time: | 11/08/2023 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$2.34 | $2.39 | $2.34 | $2.42 | $2.32 | 16,554,640 | 11-08-2023 |
$2.39 | $2.35 | $2.39 | $2.5 | $2.3 | 3,311,522 | 11-07-2023 |
$2.38 | $2.43 | $2.38 | $2.4672 | $2.36 | 2,068,658 | 11-06-2023 |
$2.47 | $2.39 | $2.47 | $2.625 | $2.365 | 4,293,049 | 11-03-2023 |
$2.34 | $2.27 | $2.34 | $2.345 | $2.235 | 2,761,371 | 11-02-2023 |
$2.26 | $2.19 | $2.26 | $2.28 | $2.15 | 2,888,125 | 11-01-2023 |
$2.18 | $2.02 | $2.18 | $2.18 | $2.02 | 2,283,766 | 10-31-2023 |
$2.04 | $2.05 | $2.04 | $2.095 | $2.01 | 1,849,703 | 10-30-2023 |
$2.05 | $2.1 | $2.05 | $2.11 | $2.04 | 3,469,504 | 10-27-2023 |
$2.13 | $2.12 | $2.13 | $2.16 | $2.1 | 1,900,875 | 10-26-2023 |
$2.1 | $2.12 | $2.1 | $2.15 | $2.09 | 3,772,321 | 10-25-2023 |
$2.16 | $2.09 | $2.16 | $2.18 | $2.09 | 12,005,171 | 10-24-2023 |
$2.105 | $2.16 | $2.105 | $2.16 | $2.05 | 6,380,751 | 10-23-2023 |
$2.28 | $2.35 | $2.28 | $2.35 | $2.25 | 1,564,428 | 10-20-2023 |
$2.3 | $2.33 | $2.3 | $2.33 | $2.275 | 1,212,731 | 10-19-2023 |
$2.33 | $2.33 | $2.33 | $2.35 | $2.295 | 1,999,654 | 10-18-2023 |
$2.35 | $2.37 | $2.35 | $2.42 | $2.34 | 5,973,414 | 10-17-2023 |
$2.39 | $2.32 | $2.39 | $2.4 | $2.3 | 2,726,726 | 10-16-2023 |
$2.32 | $2.22 | $2.32 | $2.32 | $2.19 | 2,418,014 | 10-13-2023 |
$2.21 | $2.23 | $2.21 | $2.23 | $2.19 | 2,228,252 | 10-12-2023 |
News, Short Squeeze, Breakout and More Instantly...
EQRx Inc. Company Name:
EQRX Stock Symbol:
NASDAQ Market:
Histogen Inc. (HSTO) is expected to report for Q3 2023 News Corporation (NWSA) is expected to report $0.13 for Q1 2024 TORM plc (TRMD) is expected to report for Q3 2023 Blink Charging Co. (BLNK) is expected to report $-0.47 for Q3 2023 Nuvalent Inc. (NUVL) is expected to report $-...
REDWOOD CITY, Calif. and CAMBRIDGE, Mass., Nov. 08, 2023 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (NASDAQ:RVMD), a clinical-stage oncology...
REDWOOD CITY, Calif. and CAMBRIDGE, Mass., Nov. 08, 2023 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing targeted therapies for RAS-addicted cancers, and EQRx, Inc. (Nasdaq: EQRX), announced that earlier today, at their respective specia...